|
| |
|
|
|
|
|
|
Company history
1886
Founded in Berlin
1889
First overseas sales
|
 |
|
| |
1920
Therapeutic use of the first immunological Bacterial Culture Suspension (BCS), developed by the company’s own research
1922
Launch of Posterisan®, the first anti-hemorrhoidal product containing BCS
1923
First exports to Japan (Maruho, Osaka)
1962
Inauguration of the branch facility in Constance
1980
Liaison office in New York opened
1982
Inauguration of a new, state-of-the-art pharmaceutical plant in Berlin
1992
Dr. Kade/Besins Pharma joint venture established in Germany
1997
Launch of the first progestin preparation with natural progesterone for female hormone replacement therapy
1998
Launch of an innovative estradiol gel for female hormone replacement therapy
2005
Launch of an analgesic with flupirtine for the treatment of back pain
2006
KADEFARM Sp. z o.o. joint venture established in Poland
2007
Launch of a low dosed estradiol/progestin preparation for female hormone replacement therapy
|
| |
© Dr. Kade Pharmazeutische Fabrik GmbH, Berlin 2002
last update: 10 / 18 / 2009
|
|
